Boston Society Gene and Cell Therapy Conference

March 19 - 20, 2026

Bristol Myers Squibb, 250 Water Street, Cambridge, MA 02141

Confirmed Speakers 2026

We're continuing to build the 2026 program - check back soon for more speakers and updates.

	Prof. Mimoun Azzouz School of Medicine & Population Health, Chair of Translational Neuroscience, Director of GTIMC @ University of Sheffield, UK ARDAT workstreams and objectives - talk title TBA		Amy Rosemberg, PhD Senior Director Regulatory Affairs @ Regeneron Next generation of gene edited therapies, both in vivo and ex-vivo cell therapies - talk title TBA

	Eva Andres-Mateos, PhD Associated VP Preclinical Development Gene Therapy @ Eli Lilly Translational sciences for GT/clinical data - talk title TBA

2026 Proposed Sessions

Preclinical Approaches to GCT

Preclinical Discovery & Development

Safety Tox. Assessments (in vitro//in vivo tools/models)

IND Submission Processes

Regulatory Perspectives

Industry Landscape

Clinical Approaches to GCT

Clinical Pharmacology

Modeling & Simulation/QSP

Manufacturing/CMC

Commercialization/Post Manufacturing Commitments

Patient Perspective

Please Join our LinkedIn Group

Sessions

Session I: Current State-of-the-Art Gene Delivery

Session II: Translational PK/PD and Clinical Pharmacology Aspects

Session III: Biomarkers and Clinical Translation Aspects of Gene Therapy

Registration

Click here to register for the Gene and Cell Therapy conference online.

The conference will take place March 20-21, 2025 at:

BMS, Cambridge Crossing, Cambridge, MA

The Boston Society

The Boston Society (R) is an internationally-recognized NON-PROFIT organization dedicated to bringing the best scientific ideas to industrial practice through focused, timely workshops and conferences. 501(c)3